Skip to main content

Day: October 12, 2021

TELUS recognized by Google Cloud for its social impact

TELUS Data for Good wins two Google Cloud Customer Awards in recognition of the role it played to help stem the spread of COVID-19 VANCOUVER, British Columbia, Oct. 12, 2021 (GLOBE NEWSWIRE) — TELUS is proud to announce that it has won two Google Cloud Customer Awards – the Social Impact and Communications and Service Providers Customer Awards – a worldwide recognition that reinforces TELUS’ global leadership in social capitalism, digital innovation and creative thinking. These awards acknowledge the critical role that the TELUS Data for Good program played to improve the lives of Canadians during the COVID-19 pandemic, and recognize that de-identified data can be used responsibly to support more informed decision-making and build stronger and healthier communities. “We are extremely proud to be the only Canadian company...

Continue reading

Rakovina Therapeutics Presents at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics

Presentation highlights pre-clinical data from Rakovina Therapeutics’ novel kt-3000 series dual PARP-HDAC inhibitors VANCOUVER, British Columbia, Oct. 12, 2021 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSXV: RKV) (“the Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies, today announced a summary of the Company’s presentation at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, which was held virtually on October 7-10, 2021. Rakovina Therapeutics presented a video presentation entitled In Vitro Activity of Novel kt-3000 Series Dual PARP-HDAC Inhibitors. The kt-3000 series are novel drug candidates that combine inhibition of poly (ADP-ribose) polymerase (PARP) and histone deacetylase...

Continue reading

Heartland Financial USA, Inc. Schedules Third Quarter Earnings Conference Call for October 25, 2021

DUBUQUE, Iowa, Oct. 12, 2021 (GLOBE NEWSWIRE) — Officials of Heartland Financial USA, Inc. (NASDAQ: HTLF) announced today that the company plans to broadcast a conference call detailing its Third Quarter 2021 earnings live over the internet at www.htlf.com at 5:00 p.m. ET on Monday, October 25, 2021. Lynn B. Fuller, Executive Operating Chairman; Bruce K. Lee, President and CEO, and Bryan R. McKeag, Executive Vice President and Chief Financial Officer, will conduct the conference call. Financial results will be available on the company’s website on October 25, 2021, after the market closes. There will be a question-and-answer session following the presentation. Shareholders, analysts and other interested parties are invited to join the call. Please note the new procedures for the call. Joining the Conference Call:Please register...

Continue reading

Azincourt Energy Closes Final Tranche of Private Placement For Total Proceeds of $8.1M

Not for distribution to United States Newswire Services or for dissemination in the United States VANCOUVER, British Columbia, Oct. 12, 2021 (GLOBE NEWSWIRE) — AZINCOURT ENERGY CORP. (“Azincourt” or the “Company”) (TSX.V: AAZ, OTCQB: AZURF, FSE: A0U2) is pleased to announce that it has closed the final tranche of its non-brokered private placement.  In connection with closing of the final tranche, the Company has issued 17,071,428 non-flow-through units (each, an “NFT Unit”) and 6,666,667 flow-through units (each, an “FT Unit”).  Each NFT Unit was offered at a price of $0.07 and each FT Unit was offered at a price of $0.075.  Each NFT Unit and FT Unit consists of one common share and one share purchase warrant entitling the holder to acquire an additional common share of the Company at a price of $0.10 until October 12, 2024. When...

Continue reading

Psyence Group Jamaica Chief Medical Officer Dr. Dingle Spence to Headline Two Conferences on Psychedelics

TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, is pleased to announce that Dr. Dingle Spence, the Chief Medical Officer of the Company’s wholly owned subsidiary, Psyence Jamaica Limited, will be a featured speaker at two virtual global conferences, back-to-back this week. Dr. Spence, an oncologist, palliative care specialist, and health justice activist will speak at the EndWell Conference – “The End in Mind – Psychedelic Medicines & Ending Well” taking place virtually on Thursday, October 14, 2021. Dr. Spence is also a featured speaker at the “Fantastic Fungi Global Summit – The Transformational Power of Mushrooms” taking place virtually on Friday, Saturday,...

Continue reading

Greene Concepts Extends the Sponsorship of Dawson Cram and Cram Racing Enterprises to Include Races at Martinsville Speedway and Phoenix Raceway

$INKW – Greene Concepts Extends the Sponsorship of Dawson Cram and Cram Racing Enterprises to Include Races at Martinsville Speedway and Phoenix RacewayDawson “DK” Cram$INKW – Greene Concepts Extends the Sponsorship of Dawson Cram and Cram Racing Enterprises to Include Races at Martinsville Speedway and Phoenix RacewayDawson “DK” Cram$INKW – Greene Concepts Extends the Sponsorship of Dawson Cram and Cram Racing Enterprises to Include Races at Martinsville Speedway and Phoenix RacewayDawson “DK” CramMarion, North Carolina, Oct. 12, 2021 (GLOBE NEWSWIRE) — Greene Concepts, Inc. (OTC Pink: INKW) is proud to finish the 2021 NASCAR Camping World Truck Series by extending the sponsorship of Dawson “DK” Cram to include the upcoming races held at Martinsville Speedway...

Continue reading

Form 8.5 (EPT/RI) Morrison (Wm.) Supermarkets plc *** AMENDED *** TECHNICAL ISSUE *** 08/10/21

*** AMENDED **** 8th October 2021 FORM 8.5 (EPT/RI)   PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Morrisons (WM) Supermarkets PLC(c)        Name of the party to the offer with which exempt principal trader is connected: Morrisons (WM) Supermarkets PLC(d)        Date dealing undertaken: 8 October 2021(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If...

Continue reading

Winnebago Industries’ Premium RV Brands – Winnebago, Grand Design RV, and Newmar – Each Achieve RVDA DSI Quality Circle Award Status

EDEN PRAIRIE, Minn., Oct. 12, 2021 (GLOBE NEWSWIRE) — Winnebago Industries, Inc. (NYSE: WGO), a leading outdoor lifestyle product manufacturer, today announced that all three of its RV premium brands have achieved the prestigious Quality Circle Award from the National RV Dealers Association (RVDA). The awards will be presented on November 11, during the RV Dealers Convention/Expo in Las Vegas, Nevada. The Company’s Grand Design RV, Newmar and Winnebago businesses are each being recognized as Quality Circle Award winners based on overall dealer satisfaction as measured in the Dealer Satisfaction Index (DSI) survey. RVDA created the DSI as a tool to help improve communication and relationships with RV manufacturers. The DSI survey measures four core areas related to Reliability and Quality, Parts, Warranty and Sales. To receive the...

Continue reading

CURATIVE BIOTECHNOLOGY ANNOUNCES DR. CATHERINE SOHN AS SPECIAL ADVISOR TO BOARD AND CEO

Dr. Sohn to Oversee Development of Next Gen COVID-19 Vaccine to Treat Kidney Failure Patients, Late-Stage Rabies Therapeutic and Age-related Macular Degeneration Boca Raton, FL, Oct. 12, 2021 (GLOBE NEWSWIRE) — Curative Biotechnology, Inc. (OTC: CUBT) (“Curative Biotech” or the “Company”), a development-stage biomedical company focused on novel treatments for rare diseases and conditions, announced today that Dr. Catherine Sohn has joined the Company as a Special Advisor to the Board of Directors and the CEO. Dr. Sohn is President of Sohn Health Strategies and Adjunct Professor at the University of California, San Francisco, her alma mater, where she received her Doctor of Pharmacy degree and the Distinguished Alumnus Award (2000). Dr. Sohn is currently Chairman of BioEclipse Therapeutics, a privately held, clinical-stage oncology...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.